Eligible? Enter your email with the company domain to determine your eligibility.

Am I Eligible?

By entering your location and email address, we can determine if your company is eligible to participate in the BIO Business Solutions® cost - savings programs. If your company is eligible you will be directed to a page outlining the benefits available to you.

Not in the US? View programs available in:

From Founding to Exit: A Life Science Business Founder Perspective

September 28, 2017 at 11am Pacific/2pm Eastern

Sponsored by: ShareVault, BIO, Women in Bio, and tTAp a Life Science Accelerator

Join us for a web panel discussion on how to successfully move a life science organization from founding to exit. During this discussion, founders will provide guidance on how executive teams can partner business and science together to overcome the stumbling blocks along the way and achieve results. Learn what is real and what is myth!

Hear real stories from people who have hit the trenches from the entrepreneurial business CEO perspective and have run the gauntlet to an exit. Founders will provide insight on when to bring on new talent and skill sets, when to engage partners, investors and board members and how to recognize the need to evolve as your company changes.

Join this web panel for an insightful discussion on…

  • Investor perception: science, business and the balance
  • The good, the bad and the ugly: how up-rounds, down-rounds, growth and failures impact people involved, and the ultimate outcome
  • How to listen, select and grow from feedback
  • The importance and challenges of timing, science and passion
  • How to manage change in science, corporate needs and people
  • Differences in the sector and in the exit type

Attendees will have the opportunity to ask your own questions during the discussion.

Moderator:  Caroline Hoedemaker, MBA PE | tTAp a Life Science Accelerator; VALUEDsolutions



Caroline Hoedemaker, MBA PE | tTAp a Life Science Accelerator; VALUEDsolutions (moderator)

Wendy Perrow, MBA | AsclepiX Therapeutics

Robert Alonso | Mitochon

4th Panel Speaker TBD 


To join this lively Q&A, register here:


Jan 18, 2017 | Email |